• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白、富亮氨酸重复激酶2及其在帕金森病中的相互作用

α-synuclein, LRRK2 and their interplay in Parkinson's disease.

作者信息

Liu Guoxiang, Aliaga Leonardo, Cai Huaibin

机构信息

Transgenics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Future Neurol. 2012 Mar;7(2):145-153. doi: 10.2217/fnl.12.2.

DOI:10.2217/fnl.12.2
PMID:22563296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3343692/
Abstract

Of the various genetic factors contributing to the pathogenesis of Parkinson's disease (PD), only mutations in α-synuclein (α-syn) and LRRK2 genes cause clinical and neuropathological phenotypes closely resembling the sporadic cases. Therefore, studying the pathophysiological functions of these two PD-related genes is particularly informative in understanding the underlying molecular pathogenic mechanism of the disease. PD-related missense and multiplication mutations in α-syn may cause both early- and late-onset PD, whereas various PD-related LRRK2 missense mutations may contribute to the more common late-onset PD. While intensive studies have been carried out to elucidate the pathogenic properties of PD-related mutant α-syn and LRRK2, our knowledge of their normal functions and their potential genetic interplay remains rudimental. In this review, we summarize the progress made regarding the pathophysiological functions of α-syn, LRRK2 and their interaction in PD, based on the available literature and our unpublished observations.

摘要

在导致帕金森病(PD)发病机制的各种遗传因素中,只有α-突触核蛋白(α-syn)和富含亮氨酸重复激酶2(LRRK2)基因的突变会导致临床和神经病理表型,与散发性病例极为相似。因此,研究这两个与PD相关基因的病理生理功能,对于理解该疾病潜在的分子致病机制具有特别重要的意义。α-syn中与PD相关的错义突变和倍增突变可能导致早发性和晚发性PD,而各种与PD相关的LRRK2错义突变可能导致更为常见的晚发性PD。尽管已经开展了大量研究来阐明与PD相关的突变型α-syn和LRRK2的致病特性,但我们对它们的正常功能及其潜在的基因相互作用的了解仍然十分有限。在这篇综述中,我们基于现有文献和我们未发表的观察结果,总结了α-syn、LRRK2的病理生理功能及其在PD中的相互作用方面所取得的进展。

相似文献

1
α-synuclein, LRRK2 and their interplay in Parkinson's disease.α-突触核蛋白、富亮氨酸重复激酶2及其在帕金森病中的相互作用
Future Neurol. 2012 Mar;7(2):145-153. doi: 10.2217/fnl.12.2.
2
Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance.帕金森病相关 LRRK2 干扰星形胶质细胞介导的α-突触核蛋白清除。
Mol Neurobiol. 2021 Jul;58(7):3119-3140. doi: 10.1007/s12035-021-02327-8. Epub 2021 Feb 24.
3
LRRK2 modifies α-syn pathology and spread in mouse models and human neurons.LRRK2 改变了α-突触核蛋白在小鼠模型和人类神经元中的病理和传播。
Acta Neuropathol. 2019 Jun;137(6):961-980. doi: 10.1007/s00401-019-01995-0. Epub 2019 Mar 29.
4
The role of posttranslational modifications of α-synuclein and LRRK2 in Parkinson's disease: Potential contributions of environmental factors.α-突触核蛋白和 LRRK2 的翻译后修饰在帕金森病中的作用:环境因素的潜在贡献。
Biochim Biophys Acta Mol Basis Dis. 2019 Aug 1;1865(8):1992-2000. doi: 10.1016/j.bbadis.2018.11.017. Epub 2018 Nov 24.
5
LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson's Disease?富含亮氨酸重复激酶2与α-突触核蛋白:帕金森病中各自独立还是协同发挥作用的因素?
Front Neurosci. 2020 Jun 17;14:577. doi: 10.3389/fnins.2020.00577. eCollection 2020.
6
Neurodegenerative phenotypes in an A53T α-synuclein transgenic mouse model are independent of LRRK2.在 A53T α-突触核蛋白转基因小鼠模型中,神经退行性表型与 LRRK2 无关。
Hum Mol Genet. 2012 Jun 1;21(11):2420-31. doi: 10.1093/hmg/dds057. Epub 2012 Feb 21.
7
Baseline α-synuclein seeding activity and disease progression in sporadic and genetic Parkinson's disease in the PPMI cohort.PPMI队列中散发性和遗传性帕金森病的基线α-突触核蛋白播种活性与疾病进展
medRxiv. 2025 Apr 2:2024.09.27.24311107. doi: 10.1101/2024.09.27.24311107.
8
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson's Disease: Lessons From LRRK2.从突触功能障碍到遗传性帕金森病的神经保护策略:来自LRRK2的经验教训
Front Cell Neurosci. 2020 Jul 28;14:158. doi: 10.3389/fncel.2020.00158. eCollection 2020.
9
triggers α-synuclein pathology in the transgenic mouse model of PD.在 PD 的转基因小鼠模型中触发 α-突触核蛋白病理。
Gut Microbes. 2023 Dec;15(2):2276296. doi: 10.1080/19490976.2023.2276296. Epub 2023 Nov 27.
10
Analysis of α-synuclein levels related to LRRK2 kinase activity: from substantia nigra to urine of patients with Parkinson's disease.与LRRK2激酶活性相关的α-突触核蛋白水平分析:从帕金森病患者的黑质到尿液
Anim Cells Syst (Seoul). 2021 Feb 17;25(1):28-36. doi: 10.1080/19768354.2021.1883735.

引用本文的文献

1
In vivo and in silico models of Drosophila for Parkinson's disease.用于帕金森病研究的果蝇体内和计算机模拟模型。
FEBS J. 2025 Jun 1. doi: 10.1111/febs.70140.
2
Relationship among α‑synuclein, aging and inflammation in Parkinson's disease (Review).帕金森病中α-突触核蛋白、衰老与炎症之间的关系(综述)
Exp Ther Med. 2023 Nov 21;27(1):23. doi: 10.3892/etm.2023.12311. eCollection 2024 Jan.
3
Mitochondrial Dysfunction in Dopaminergic Neurons Derived from Patients with LRRK2- and SNCA-Associated Genetic Forms of Parkinson's Disease.

本文引用的文献

1
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation.α-突触核蛋白在生理条件下以螺旋折叠的四聚体形式存在,能够抵抗聚集。
Nature. 2011 Aug 14;477(7362):107-10. doi: 10.1038/nature10324.
2
LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice.LRRK2 蛋白水平由激酶功能决定,对小鼠的肾脏和肺部稳态至关重要。
Hum Mol Genet. 2011 Nov 1;20(21):4209-23. doi: 10.1093/hmg/ddr348. Epub 2011 Aug 9.
3
A BACwards glance at neurodegeneration: molecular insights into disease from LRRK2, SNCA and MAPT BAC-transgenic mice.
源自携带与LRRK2和SNCA相关基因形式帕金森病患者的多巴胺能神经元中的线粒体功能障碍
Curr Issues Mol Biol. 2023 Oct 17;45(10):8395-8411. doi: 10.3390/cimb45100529.
4
Consequences of Disturbing Manganese Homeostasis.扰乱锰稳态的后果。
Int J Mol Sci. 2023 Oct 6;24(19):14959. doi: 10.3390/ijms241914959.
5
Modelling the functional genomics of Parkinson's disease in Caenorhabditis elegans: LRRK2 and beyond.在秀丽隐杆线虫中对帕金森病的功能基因组学进行建模:LRRK2 及其他。
Biosci Rep. 2021 Sep 30;41(9). doi: 10.1042/BSR20203672.
6
The Nigral Coup in Parkinson's Disease by α-Synuclein and Its Associated Rebels.帕金森病中α-突触核蛋白及其相关“叛乱者”引发的黑质打击。
Cells. 2021 Mar 9;10(3):598. doi: 10.3390/cells10030598.
7
Manganese Accumulation in the Brain via Various Transporters and Its Neurotoxicity Mechanisms.锰在大脑中的蓄积及其神经毒性机制。
Molecules. 2020 Dec 12;25(24):5880. doi: 10.3390/molecules25245880.
8
Examination of Adsorption Orientation of Amyloidogenic Peptides Over Nano-Gold Colloidal Particle Surfaces.研究金纳米胶体粒子表面上淀粉样肽的吸附取向。
Int J Mol Sci. 2019 Oct 28;20(21):5354. doi: 10.3390/ijms20215354.
9
Bioenergetics and Autophagic Imbalance in Patients-Derived Cell Models of Parkinson Disease Supports Systemic Dysfunction in Neurodegeneration.帕金森病患者来源细胞模型中的生物能量学与自噬失衡支持神经退行性变中的全身功能障碍
Front Neurosci. 2019 Sep 10;13:894. doi: 10.3389/fnins.2019.00894. eCollection 2019.
10
Manganese-Induced Neurotoxicity: New Insights Into the Triad of Protein Misfolding, Mitochondrial Impairment, and Neuroinflammation.锰诱导的神经毒性:蛋白质错误折叠、线粒体损伤和神经炎症三联征的新见解
Front Neurosci. 2019 Jun 26;13:654. doi: 10.3389/fnins.2019.00654. eCollection 2019.
BACward 一瞥神经退行性变:LRRK2、SNCA 和 MAPT BAC 转基因小鼠的疾病分子见解。
Biochem Soc Trans. 2011 Aug;39(4):862-7. doi: 10.1042/BST0390862.
4
Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications.帕金森病的 LRRK2 基因突变模型:解析致病途径并探索临床应用。
Mov Disord. 2011 Jul;26(8):1386-97. doi: 10.1002/mds.23737. Epub 2011 Apr 29.
5
Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2).Rac1 蛋白挽救了 G2019S 亮氨酸丰富重复激酶 2(LRRK2)引起的神经突回缩。
J Biol Chem. 2011 May 6;286(18):16140-9. doi: 10.1074/jbc.M111.234005. Epub 2011 Mar 16.
6
Autophagic pathways in Parkinson disease and related disorders.帕金森病及相关疾病中的自噬途径。
Expert Rev Mol Med. 2011 Mar 21;13:e8. doi: 10.1017/S1462399411001803.
7
Phosphorylation-dependent 14-3-3 binding to LRRK2 is impaired by common mutations of familial Parkinson's disease.磷酸化依赖的 14-3-3 与 LRRK2 的结合受到家族性帕金森病常见突变的影响。
PLoS One. 2011 Mar 1;6(3):e17153. doi: 10.1371/journal.pone.0017153.
8
Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease.14-3-3 蛋白在帕金森病模型中的差异神经保护作用。
Cell Death Dis. 2010;1(1):e2. doi: 10.1038/cddis.2009.4.
9
Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2.LRRK2 基因 G2019S 突变的帕金森病患者线粒体功能障碍。
Neurology. 2010 Nov 30;75(22):2017-20. doi: 10.1212/WNL.0b013e3181ff9685.
10
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease.富含亮氨酸重复激酶 2(LRRK2)在帕金森病中的作用。
Nat Rev Neurosci. 2010 Dec;11(12):791-7. doi: 10.1038/nrn2935. Epub 2010 Nov 19.